Table 2. Demographic and clinical characteristics of healthy individuals after the intravenous administration of NMN.

The results are expressed as mean ± standard deviation (n = 10). NMN: Nicotinamide mononucleotide.

Variable	Pre-treatment		Post-treatment
Age (years)	43.4 (±12.6)		43.4 (±12.6)
Weight (kg)	66.1 (±9.6)		65.7 (±9.6)
Body mass index (kg/m2)	24.4 (±3.5)		24.3 (±3.4)
Electrocardiogram	Normal		Normal
Chest X-ray	Normal		Normal